1. Schalkhäuser, K., Adam, D. Zur Diffusion von Cefotaxim in verschiedene Geweben des urologischen Bereichs. Infection 8, Suppl. 3 (1980) S 327-S 330.
2. Genov, A., Riedel, B., Savopoulos, C., Seeger, K., Seidel, G. Cefotaxime concentrations in prostatic tissue. Infection 11 (1983) 33–34.
3. Blind, R., Bikfalvi, A., Seeger, K., Seidel, G., Savopoulos, C. Cefotaxime in human lung tissue. Arzneim.-Forsch. 32 (1982) 1319–1321.
4. Dette, G. A., Knothe, H., Zeh, K. P., Van Laak, U. Indications of cefotaxime underestimation in tissues and clinical samples. Drugs. Exptl. Clin. Res. 8 (1983) 633–637.
5. White, L. O., Holt, H. A., Reeves, D. S., Bywater, M. J., Bax, R. P. Separation and assay of cefotaxime (HR-756) and its metabolites in serum, urine, and bile. In:Nelson, J. D., Grassi, C. (eds.): Current chemotherapy of infectious diseases. Vol. I., American Society for Microbiology, Washington 1980, pp. 153–154.